Fu, Haoda

The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes

Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013) · Cell Metabolism

Fibroblast Growth Factor ResearchAdipokines, Inflammation, and Metabolic Diseases

Cited by 885

Short‐term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes

Kelly, R. P., Garhyan, P., Raddad, E., Fu, H., Lim, C. N., Prince, M. J., Pinaire, J. A., Loh, M. T., & Deeg, M. A. (2015) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 110

Enabling Eating Detection in a Free-living Environment: Integrative Engineering and Machine Learning Study (Preprint)

Zhang, B., Deng, K., Shen, J., Cai, L., Ratitch, B., Fu, H., & Guan, Y. (2021) · Journal of Medical Internet Research

Context-Aware Activity Recognition SystemsMobile Health and mHealth Applications

Cited by 5

Enabling Eating Detection in a Free-living Environment: Integrative Engineering and Machine Learning Study

Zhang, B., Deng, K., Shen, J., Cai, L., Ratitch, B., Fu, H., & Guan, Y. (2022) · Journal of Medical Internet Research

Context-Aware Activity Recognition SystemsMobile Health and mHealth Applications

Cited by 5